| Ultra-sensitive Soluble uPAR/CD87 ELISA | |
Alternative name:
|
|
|
Human Ultra-sensitive Soluble uPAR/CD87 ELISA Code No.: SK00561-01 Size: 96 T Price: $420.00 USD Standard Range:4.7-300 pg/ml Sensitivity: 2 pg/ml Sample Type: serum, plasma Sample Volume: 100 uL of diluted samples Dilution Factor: Intra CV: 4-6% Inter CV: 8-10% Protocol: PDF |
|
|
 ELISA Kit.png)
| Name | Code No. |
Size |
Price ($) |
| Human Ultra-sensitive Soluble uPAR/CD87 ELISA Kit | 96 T |
420.00 |
References
1: Bache M et al. Nanomechanical recognition of prognostic biomarker suPAR with DVD-ROM optical technology. Nanotechnology. 2013 Nov 8;24(44):444011.
2: Quirico-Santos T, et al. Increased metalloprotease activity in the epileptogenic lesion-Lobectomy reduces metalloprotease activity and urokinase-type uPAR circulating levels. Brain Res. 2013 Oct 1. doi:pii: S0006-8993(13)01318-8.10.1016/j.brainres.2013.09.044..
3: El-Remessy AB, et al. Diabetes-induced superoxide anion and breakdown of the blood-retinal barrier:
role of the VEGF/uPAR pathway. PLoS One. 2013;8(8):e71868. doi:10.1371/journal.pone.0071868.
4: Nebuloni M, et al. HIV-1 infected lymphoid organs upregulate expression and release of the cleaved form of uPAR that modulates chemotaxis and virus expression. PLoS One. 2013 Jul 29;8(7):e70606. doi: 10.1371/journal.pone.0070606.
5: Enocsson H, et al. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus. Transl Res. 2013 Aug 1. doi:pii: S1931-5244(13)00211-9.
6: Kiyan Y, et al. Urokinase receptor counteracts vascular smooth muscle cell functional changes induced by
surface topography. Theranostics. 2013 Jul 3;3(7):516-26. doi: 10.7150/thno.4119.
7: Noh H, et al. Role of urokinase receptor in tumor progression and development. Theranostics. 2013 Jun 25;3(7):487-95. doi: 10.7150/thno.4218. Print. 2013
8: Rao JS, et al. Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis. Oncogenesis. 2013 Jun 24;2:e53. doi: 10.1038/oncsis.2013.19.
9: Wang Q, et al. The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with
chronic obstructive pulmonary disease. Respir Res. 2013 Jun 28;14:67. doi:10.1186/1465-9921-14-67.